Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3158-3168
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3158
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3158
Figure 2 Yiqi Jiedu Huayu increased the secretion of gastric mucosal-related factors and reduced inflammatory factors secretion in chronic atrophic gastritis rats with precancerous lesion of gastric cancer.
The gastric mucosal-related factors and inflammatory factors were measure before and after Yiqi Jiedu Huayu decoction treatment in the chronic atrophic gastritis rats with precancerous lesion of gastric cancer. A: Serum interleukin-6 level was determined by enzyme-linked immunosorbent assay (ELISA); B: Serum tumor necrosis factor-α level was determined by ELISA; C: Serum C-reactive protein level was determined by ELISA; D: Serum gastrin level was determined by ELISA; E: Serum pepsin level was determined by ELISA; F: Serum somatostatin was determined by ELISA; G: Serum prostaglandin E2 level was determined by ELISA. The measurement data were presented as mean ± SD. n = 10. aP < 0.05, bP < 0.01, cP < 0.001. YJHD: Yiqi Jiedu Huayu decoction; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; CRP: C-reactive protein.
- Citation: Zhou P, Zheng ZH, Wan T, Liao CW, Wu J. Yiqi Jiedu Huayu decoction inhibits precancerous lesions of chronic atrophic gastritis by inhibiting NLRP3 inflammasome-mediated pyroptosis. World J Gastrointest Oncol 2024; 16(7): 3158-3168
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3158.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3158